Endocellutions, Inc. is a biotech company specializing in the development of innovative cell-based therapies for a wide range of diseases and disorders. Our mission is to harness the power of endogenous stem cells to revolutionize the field of regenerative medicine. With a team of experienced scientists and cutting-edge technology, we aim to bring new hope to patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

9 Patents

#3 in Marshfield, MA

#1,926 in Massachusetts

#32,627 in US

Marshfield, MA, United States of America

Endocellutions, Inc.

Forward Citations = 106

7 inventors:

Neil Francis Duffy (7 out of 11 patents)

Andrew McGillicuddy (6 out of 18 patents)

Jeffrey Raymond Chabot (4 out of 10 patents)

4. Andy H Levine (3 out of 101 patents)

5. John C Meade (1 out of 122 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Endocellutions, Inc.. Retrieved from https://idiyas.com/company/endocellutions

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]